Baekgyu Choi

Baekgyu Choi

Auto-generated profile, based on publicly available information

Baekgyu Choi

Korea Advanced Institute of Science and Technology (KAIST) 1 Department of Biological Sciences Daejeon, Republic of Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in Science Immunology
Verified
Journal Article
Open access
PDF file
JLJeong Seok Lee
Jeong Seok Lee
SPSeongwan Park
Seongwan Park
HJHye Won Jeong
Hye Won Jeong
JAJin Young Ahn
Jin Young Ahn
SCSeong Jin Choi
Seong Jin Choi
ESEui-Cheol Shin
Eui-Cheol Shin
Single-cell RNA sequencing of blood immune cells reveals type I interferon–associated hyper-inflammation in severe COVID-19.

14 April 2023 in Science Advances
Verified
Journal Article
Open access
ALAndrew J. Lee
Andrew J. Lee
CKChangyoun Kim
Changyoun Kim
SPSeongwan Park
Seongwan Park
JJJaegeon Joo
Jaegeon Joo
BCBaekgyu Choi
Baekgyu Choi
IJInkyung Jung
Inkyung Jung
Parkinson’s disease (PD) is a progressive neurodegenerative disorder. However, cell type–dependent transcriptional regulatory programs responsible for PD pathogenesis remain elusive. Here, we establish transcriptomic and epigenomic landscapes of the substantia nigra by profiling 113,207 nuclei obtained from healthy controls and patients with PD. Our multiomics data integration provides cell type annotation of 128,724 cis-regulatory elements (cREs) and uncovers cell type–specific dysregulations in cREs with a strong transcriptional influence on genes implicated in PD. The establishment of high-resolution three-dimensional chromatin contact maps identifies 656 target genes of dysregulated cREs and genetic risk loci, uncovering both potential and known PD risk genes. Notably, these candidate genes exhibit modular gene expression patterns with unique molecular signatures in distinct cell types, highlighting altered molecular mechanisms in dopaminergic neurons and glial cells including oligodendrocytes and microglia. Together, our single-cell transcriptome and epigenome reveal cell type–specific disruption in transcriptional regulations related to PD.

1 September 2019
Verified
Journal Article
Open access
BKBonsang Koo
Bonsang Koo
BCBaekgyu Choi
Baekgyu Choi
HPHoewon Park
Hoewon Park
KYKi-Jun Yoon
Ki-Jun Yoon
Brain organoids are an exciting new technology with the potential to significantly change our understanding of the development and disorders of the human brain. With step-by-step differentiation protocols, three-dimensional neural tissues are self-organized from pluripotent stem cells, and recapitulate the major millstones of human brain development in vitro. Recent studies have shown that brain organoids can mimic the spatiotemporal dynamicity of neurogenesis, the formation of regional neural circuitry, and the integration of glial cells into a neural network. This suggests that brain organoids could serve as a representative model system to study the human brain. In this review, we will overview the development of brain organoid technology, its current progress and applications, and future prospects of this technology.

26 June 2026 in Cancer Research
Verified
Journal Article
Closed access
ALAndrew J. Lee
Andrew J. Lee
SMSunwoo Min
Sunwoo Min
SPSu Chan Park
Su Chan Park
MQMei-Yu Qiu
Mei-Yu Qiu
JBJeong Mo Bae
Jeong Mo Bae
IJInkyung Jung
Inkyung Jung
The transition of endothelial cells (EC) to tumor-associated ECs (TEC) is a critical process in tumor progression. The underlying mechanisms driving this angiogenic state could represent potential therapeutic targets. In this study, we revealed that a co-opted gene regulatory program from EC progenitors promotes the angiogenic phenotypes of TECs. Specifically, the TEC-specific gene regulatory program, derived from large-scale single-cell transcriptomic and epigenomic atlases across multiple solid tumors, was projected onto multiomic maps of human embryonic stem cell–derived EC differentiation. TECs reactivated a gene regulatory program governing extracellular matrix remodeling originally confined to the late EC progenitor state. Notably, integrin αv emerged as a mediator associated with endothelial plasticity in the tumor microenvironment (TME). Stimulation of primary ECs with predicted TME ligands reactivated these progenitor-associated regulatory programs, whereas inhibition of integrin αv attenuated this effect, suppressing endothelial migration, invasion, and tumor vascularization in vivo. Collectively, these findings reveal that tumor endothelial plasticity is governed by the co-option of a developmental cis-regulatory program, highlighting a regulatory mechanism underlying TEC adaptation in tumors and providing a rational therapeutic strategy to counteract angiogenic reprogramming. Significance: Tumors exploit intrinsic endothelial differentiation programs to drive vascular evolution, providing a conceptual framework for targeting endothelial plasticity as an anti-angiogenic strategy.

2 September 2026
Verified
Other
Open access
ALAndrew J. Lee
Andrew J. Lee
SMSunwoo Min
Sunwoo Min
SPSu Chan Park
Su Chan Park
MQMei-Yu Qiu
Mei-Yu Qiu
JBJeong Mo Bae
Jeong Mo Bae
IJInkyung Jung
Inkyung Jung
List of differentially expressed genes in ligand-treated HUVECs

2 September 2026
Verified
Other
Open access
PDF file
ALAndrew J. Lee
Andrew J. Lee
SMSunwoo Min
Sunwoo Min
SPSu Chan Park
Su Chan Park
MQMei-Yu Qiu
Mei-Yu Qiu
JBJeong Mo Bae
Jeong Mo Bae
IJInkyung Jung
Inkyung Jung
Single-cell chromatin accessibility profiling of endothelial populations from colorectal tumors and adjacent normal mucosa